Home
Syapse

Syapse Market Share Analysis for May 2026

Our clinical research platform empowers oncology practices and biopharma companies to accelerate drug development with technology and trained personnel.

Health > Health - Other

Domainsyapse.com

Year Founded2008

Employees51 - 200

Annual Revenue$25M - $50M

Syapse

Syapse (including company regionals)

syapse.com

See more website traffic and engagement information

Syapse Revenue up to May 2026 is 25M - 50M

revenue generated by Syapse top domains

Syapse top domains revenue over 3 years

Revenue for Syapse top domains

syapse.com25M - 50M

See more with Sales Intelligence

Total visits to Syapse's top domains

Understand Syapse market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Syapse's top domains

Analyze Syapse engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Syapse's top domains

See how Syapse keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Syapse top competitors by domain

Top similar sites in May 2026, ranked by their affinity

ivantagehealth.comCompany NameiVantage Health AnalyticsEmployees51 - 200HQUnited States, Massachusetts, NewtonAnnual revenue$15M - $25MTotal visits--Health > Health - Other

Top technologies used by Syapse

These are the website technologies, by industry, used by Syapse top domains

Advertising (4)

DoubleClick

Marketing (4)

Google Marketing Platform

Content Management System (3)

Medium

Audio Video Media (2)

YouTube

More Technologies

8

See all

News & Signals from Syapse

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsN-Power Medicine, Inc. acquired Syapse, Inc on Jan 12th '25.N-Power Medicine, a company leading the reinvention of the clinical trial process, today announced the acquisition of Syapse Holdings Inc. ("Syapse"), a pioneer in precision medicine solutions for community cancer centers.

NewsSyapse, Inc launched precision medicine collaboration in oncology on May 2nd '19.On May 2, 2019- Amgen, a world leader in biotechnology, and Syapse, a company powering precision medicine insights through its global provider network, has announced a precision medicine collaboration in oncology.

NewsSyapse, Inc partnered with Merck on Oct 6th '21.Syapse ®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, has entered a collaboration with Merck, known as MSD, outside the United States and Canada, to leverage Syapse’s leading real-world evidence solutions designed to improve outcomes for cancer patients.